Repligen (RGEN) Inventory (2011 - 2026)

Repligen (RGEN) has 16 years of Inventory data on file, last reported at $179.3 million in Q1 2026.

• On a quarterly basis, Inventory rose 17.08% year-over-year to $179.3 million in Q1 2026; TTM through Mar 2026 was $179.3 million, a 17.08% increase from a year earlier, with the FY2025 full-year figure at $170.5 million, up 19.23% from the prior year.
• Inventory for Q1 2026 stood at $179.3 million, up from $170.5 million in the prior quarter.
• Over the last five years, Inventory for RGEN reached as high as $244.7 million in Q1 2023 and fell as low as $143.0 million in Q4 2024.
• Historically, Inventory has averaged $198.0 million across 5 years, with a median of $198.0 million in 2024.
• Across the five-year window, Inventory soared 95.19% in 2022 and decreased 29.34% in 2024, its largest moves.
• Year by year, Inventory stood at $238.3 million in 2022, then slipped by 15.09% to $202.3 million in 2023, then dropped by 29.34% to $143.0 million in 2024, then advanced by 19.23% to $170.5 million in 2025, then rose by 5.16% to $179.3 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $179.3 million in Q1 2026, $170.5 million in Q4 2025, and $160.3 million in Q3 2025.